Company Analysis
Sign in

Alvotech (ALVO)

Nasdaq: ALVO · Biological Products, (No Diagnostic Substances) · Luxembourg, LU · filing with the SEC since 2021
Full chart Alerts Compare
Grade6.2
◀ Past 7.3● Present 6.0▶ Future 5.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedMar 31, 2026Mar 27, 2025Mar 20, 2024Mar 1, 2023··
Revenue586,321489,68291,43483,02936,77266,616
Cost of revenue235,558185,309160,85664,0950·
Research and development184,193171,312210,827180,622191,006148,072
General and administrative90,94665,71376,559186,74284,13458,914
Operating income78,20769,644-354,860-346,442-235,456-137,537
Finance costs149,190303,165267,157188,419117,361161,551
Finance income198,49280,1454,8232,54951,5685,608
Other gains and losses58,141-287,207-296,189-205,20586,258-154,233
Income before income taxes136,348-217,563-651,049-551,647-149,198-291,770
Income tax expense108,42914,301-99,318-38,067-47,694-121,726
Net income27,919-231,864-551,731-513,580-101,504-170,044
Earnings per share, basic0.10-0.87-2.43-2.60-0.92-1.82
Earnings per share, diluted0.10-0.87-2.43-2.60-0.92-1.82
Weighted average shares, basic289,727,741267,924,570227,256,469197,721,710110,673,30993,648,813
Weighted average shares, diluted291,342,475267,924,570227,256,469197,721,710110,673,30993,648,813
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:RevenueFromContractsWithCustomers
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Other gains and losses gains and costs outside the businessifrs-full:OtherGainsLosses
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton ALVO · research, not advice